BVS Similar Chart Price Prediction
The price of BVS is predicted to go up -1.97%, based on the high correlation periods with CSTM. The similarity of these two price pattern on the periods is 96.37%.
BVS
CSTM
Down: -1.97%Similarity: 96.37%
BVS Revenue Forecast
BVS EPS Forecast
BVS FAQs
What is revenue forecast for next quarter？
What is eps forecast for next quarter？
BVS Analyst's Forecast
Robbie Marcus
JP Morgan
Sell → Hold
Price Target
$12 → $13
Upside
+16.54%
JPMorgan upgraded Bioventus to Neutral from Underweight with a price target of $13, up from $12. The firm cites better visibility into the company's growth and several quarters of improved execution for the upgrade. 2024 marked a return to stability for Bioventus, with hyaluronic acid headwinds now lapped and "fully in the rearview and pockets of strength in areas like Ultrasonics," the analyst tells investors in a research note. As such, JPMorgan feels incrementally more positive about Bioventus into 2025.
Alexander Nowak
Craig-Hallum
Strong Buy
Price Target
$12 → $17
Upside
+40.15%